Epigenetic Targeting with EZH2 and HDAC Inhibitors Is Synergistic in EZH2 Deregulated Lymphomas

Lue Jennifer Kimberly; Prabhu Sathyen A.; Liu Yuxuan; OConnor Owen A.; Amengual Jennifer E.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Epigenetic Targeting with EZH2 and HDAC Inhibitors Is Synergistic in EZH2 Deregulated Lymphomas

【24h】

Epigenetic Targeting with EZH2 and HDAC Inhibitors Is Synergistic in EZH2 Deregulated Lymphomas

机译：用EzH2和HDAC抑制剂靶向靶向靶向靶向抑制剂在EZH2 Deregutated淋巴瘤中是协同的

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology 》 |2016年第22期| 共5页
作者
Lue Jennifer Kimberly; Prabhu Sathyen A.; Liu Yuxuan; OConnor Owen A.; Amengual Jennifer E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Epigenetic Targeting with EZH2 and HDAC Inhibitors Is Synergistic in EZH2 Deregulated Lymphomas [J] . Lue Jennifer Kimberly, Prabhu Sathyen A., Liu Yuxuan, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：用EzH2和HDAC抑制剂靶向靶向靶向靶向抑制剂在EZH2 Deregutated淋巴瘤中是协同的
2. Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas [J] . ZhangX., ZhaoX., FiskusW., Cancer Cell . 2012 ,第4期

机译：HDAC3和EZH2协同沉默MYC介导的miR-29作为侵袭性B细胞淋巴瘤中组蛋白修饰的治疗靶标
3. MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9 [J] . Jin Qifang, He Wenfeng, Chen Leifeng, Experimental and therapeutic medicine . 2018 ,第3aPta1期

机译：MicroRNA-101-3P通过靶向EZH2和HDAC9来抑制视网膜细胞瘤细胞的增殖
4. Exploring the role of EZH2 (PRC2) as epigenetic target [C] . Imlimaong Aier, Utkarsh Raj 2016 International Conference on Bioinformatics and Systems Biology . 2016

机译：探索EZH2（PRC2）作为表观遗传靶的作用
5. Epigenetic Targeted Drug Discovery: Inhibitors of Methyltransferase G9a and Dual Inhibitors of G9a and HDAC [D] . Soumyanarayanan, Uttara. 2016

机译：表观遗传靶向药物发现：甲基转移酶G9a的抑制剂和G9a和HDAC的双重抑制剂
6. Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells [O] . Natalie Grinshtein, Constanza C. Rioseco, Richard Marcellus, 1967

机译：小分子表观遗传学筛选可识别靶向胶质母细胞瘤脑肿瘤起始细胞的新型EZH2和HDAC抑制剂
7. DUAL INHIBITION OF EZH2 AND HDAC IS SYNERGISTIC IN EZH2 DYSREGULATED LYMPHOMAS [O] . J.K. Lue, S.A. Prabhu, Y. Liu, 2017

机译：EZH2和HDAC的双重抑制在EZH2失调的淋巴瘤中是协同的

Epigenetic Targeting with EZH2 and HDAC Inhibitors Is Synergistic in EZH2 Deregulated Lymphomas

著录项

相似文献

相关主题

期刊订阅